Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Neuroendocrine Tumor Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neuroendocrine Tumor Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neuroendocrine Tumor Treatment Overall Market Size
2.1 Global Neuroendocrine Tumor Treatment Market Size: 2022 VS 2029
2.2 Global Neuroendocrine Tumor Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neuroendocrine Tumor Treatment Players in Global Market
3.2 Top Global Neuroendocrine Tumor Treatment Companies Ranked by Revenue
3.3 Global Neuroendocrine Tumor Treatment Revenue by Companies
3.4 Top 3 and Top 5 Neuroendocrine Tumor Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Neuroendocrine Tumor Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neuroendocrine Tumor Treatment Players in Global Market
3.6.1 List of Global Tier 1 Neuroendocrine Tumor Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Neuroendocrine Tumor Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Neuroendocrine Tumor Treatment Market Size Markets, 2022 & 2029
4.1.2 Everolimus
4.1.3 Sunitinib
4.1.4 Lu-Dotatate
4.1.5 Lanreotide
4.1.6 Octreotide
4.2 By Type - Global Neuroendocrine Tumor Treatment Revenue & Forecasts
4.2.1 By Type - Global Neuroendocrine Tumor Treatment Revenue, 2018-2023
4.2.2 By Type - Global Neuroendocrine Tumor Treatment Revenue, 2024-2029
4.2.3 By Type - Global Neuroendocrine Tumor Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neuroendocrine Tumor Treatment Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Neuroendocrine Tumor Treatment Revenue & Forecasts
5.2.1 By Application - Global Neuroendocrine Tumor Treatment Revenue, 2018-2023
5.2.2 By Application - Global Neuroendocrine Tumor Treatment Revenue, 2024-2029
5.2.3 By Application - Global Neuroendocrine Tumor Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Neuroendocrine Tumor Treatment Market Size, 2022 & 2029
6.2 By Region - Global Neuroendocrine Tumor Treatment Revenue & Forecasts
6.2.1 By Region - Global Neuroendocrine Tumor Treatment Revenue, 2018-2023
6.2.2 By Region - Global Neuroendocrine Tumor Treatment Revenue, 2024-2029
6.2.3 By Region - Global Neuroendocrine Tumor Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Neuroendocrine Tumor Treatment Revenue, 2018-2029
6.3.2 US Neuroendocrine Tumor Treatment Market Size, 2018-2029
6.3.3 Canada Neuroendocrine Tumor Treatment Market Size, 2018-2029
6.3.4 Mexico Neuroendocrine Tumor Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Neuroendocrine Tumor Treatment Revenue, 2018-2029
6.4.2 Germany Neuroendocrine Tumor Treatment Market Size, 2018-2029
6.4.3 France Neuroendocrine Tumor Treatment Market Size, 2018-2029
6.4.4 U.K. Neuroendocrine Tumor Treatment Market Size, 2018-2029
6.4.5 Italy Neuroendocrine Tumor Treatment Market Size, 2018-2029
6.4.6 Russia Neuroendocrine Tumor Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Neuroendocrine Tumor Treatment Market Size, 2018-2029
6.4.8 Benelux Neuroendocrine Tumor Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Neuroendocrine Tumor Treatment Revenue, 2018-2029
6.5.2 China Neuroendocrine Tumor Treatment Market Size, 2018-2029
6.5.3 Japan Neuroendocrine Tumor Treatment Market Size, 2018-2029
6.5.4 South Korea Neuroendocrine Tumor Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Neuroendocrine Tumor Treatment Market Size, 2018-2029
6.5.6 India Neuroendocrine Tumor Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Neuroendocrine Tumor Treatment Revenue, 2018-2029
6.6.2 Brazil Neuroendocrine Tumor Treatment Market Size, 2018-2029
6.6.3 Argentina Neuroendocrine Tumor Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neuroendocrine Tumor Treatment Revenue, 2018-2029
6.7.2 Turkey Neuroendocrine Tumor Treatment Market Size, 2018-2029
6.7.3 Israel Neuroendocrine Tumor Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Neuroendocrine Tumor Treatment Market Size, 2018-2029
6.7.5 UAE Neuroendocrine Tumor Treatment Market Size, 2018-2029
7 Neuroendocrine Tumor Treatment Companies Profiles
7.1 Exelixis, Inc.
7.1.1 Exelixis, Inc. Company Summary
7.1.2 Exelixis, Inc. Business Overview
7.1.3 Exelixis, Inc. Neuroendocrine Tumor Treatment Major Product Offerings
7.1.4 Exelixis, Inc. Neuroendocrine Tumor Treatment Revenue in Global Market (2018-2023)
7.1.5 Exelixis, Inc. Key News & Latest Developments
7.2 Advanced Accelerator Applications
7.2.1 Advanced Accelerator Applications Company Summary
7.2.2 Advanced Accelerator Applications Business Overview
7.2.3 Advanced Accelerator Applications Neuroendocrine Tumor Treatment Major Product Offerings
7.2.4 Advanced Accelerator Applications Neuroendocrine Tumor Treatment Revenue in Global Market (2018-2023)
7.2.5 Advanced Accelerator Applications Key News & Latest Developments
7.3 Dauntless Pharmaceuticals, Inc.
7.3.1 Dauntless Pharmaceuticals, Inc. Company Summary
7.3.2 Dauntless Pharmaceuticals, Inc. Business Overview
7.3.3 Dauntless Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Major Product Offerings
7.3.4 Dauntless Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Revenue in Global Market (2018-2023)
7.3.5 Dauntless Pharmaceuticals, Inc. Key News & Latest Developments
7.4 Hutchinson Medipharma Limited
7.4.1 Hutchinson Medipharma Limited Company Summary
7.4.2 Hutchinson Medipharma Limited Business Overview
7.4.3 Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Major Product Offerings
7.4.4 Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Revenue in Global Market (2018-2023)
7.4.5 Hutchinson Medipharma Limited Key News & Latest Developments
7.5 Ispen
7.5.1 Ispen Company Summary
7.5.2 Ispen Business Overview
7.5.3 Ispen Neuroendocrine Tumor Treatment Major Product Offerings
7.5.4 Ispen Neuroendocrine Tumor Treatment Revenue in Global Market (2018-2023)
7.5.5 Ispen Key News & Latest Developments
7.6 Novartis AG
7.6.1 Novartis AG Company Summary
7.6.2 Novartis AG Business Overview
7.6.3 Novartis AG Neuroendocrine Tumor Treatment Major Product Offerings
7.6.4 Novartis AG Neuroendocrine Tumor Treatment Revenue in Global Market (2018-2023)
7.6.5 Novartis AG Key News & Latest Developments
7.7 Progenics Pharmaceuticals, Inc.
7.7.1 Progenics Pharmaceuticals, Inc. Company Summary
7.7.2 Progenics Pharmaceuticals, Inc. Business Overview
7.7.3 Progenics Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Major Product Offerings
7.7.4 Progenics Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Revenue in Global Market (2018-2023)
7.7.5 Progenics Pharmaceuticals, Inc. Key News & Latest Developments
7.8 Tarveda Therapeutics
7.8.1 Tarveda Therapeutics Company Summary
7.8.2 Tarveda Therapeutics Business Overview
7.8.3 Tarveda Therapeutics Neuroendocrine Tumor Treatment Major Product Offerings
7.8.4 Tarveda Therapeutics Neuroendocrine Tumor Treatment Revenue in Global Market (2018-2023)
7.8.5 Tarveda Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer